| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/12/2006 | WO2006003488A2 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 01/12/2006 | WO2006003427A1 A protein involved in carcinoma |
| 01/12/2006 | WO2006003422A1 Use of the receptor gpr86 |
| 01/12/2006 | WO2006003355A1 Purification of dna molecules |
| 01/12/2006 | WO2006003100A1 Functional screening assay |
| 01/12/2006 | WO2006002853A1 Synthesis of spider dragline and/or flagelliform proteins |
| 01/12/2006 | WO2006002850A2 OsK1 DERIVATIVES |
| 01/12/2006 | WO2006002827A1 Proteins of natural origin and materials made therefrom |
| 01/12/2006 | WO2006002646A2 Novel carbamylated epo and method for its production |
| 01/12/2006 | WO2005118821A3 Generation of plants with altered oil content |
| 01/12/2006 | WO2005110456A3 T-cell death-inducing epitopes |
| 01/12/2006 | WO2005101014A3 Diagnostic and therapeutic use of kcnc1 for neurodegenerative diseases |
| 01/12/2006 | WO2005090573A3 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 01/12/2006 | WO2005085417A3 Bacterial system for protein transport in eukaryotic cells |
| 01/12/2006 | WO2005075655A3 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 01/12/2006 | WO2005074981A3 Inhibitors of tgf-r signaling for treatment of cns disorders |
| 01/12/2006 | WO2005070448A3 Methods of use for secreted frizzled-related protein 3 (sfrp-3) in the prevention and treatment of disease |
| 01/12/2006 | WO2005070023A3 Expression of apoa-1 and variants thereof using spliceosome mediated rna trans-splicing |
| 01/12/2006 | WO2005069762A3 Bacillus licheniformis chromosome |
| 01/12/2006 | WO2005060364A3 Spatial for altering cell proliferation |
| 01/12/2006 | WO2005046449A3 Soluble tcr molecules and methods of use |
| 01/12/2006 | WO2005033266A3 Regulation of acheron expression |
| 01/12/2006 | WO2005027836A3 Immunogen |
| 01/12/2006 | WO2005009335A3 Live attenuated nidovirus vaccines |
| 01/12/2006 | WO2005003303A3 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/12/2006 | WO2004078130A3 Posh interacting proteins and related methods |
| 01/12/2006 | WO2004074431A3 Plant ion channels and related methods |
| 01/12/2006 | WO2004067712A3 Intracellular signaling molecules |
| 01/12/2006 | WO2004062597A3 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 01/12/2006 | WO2004056974A3 Mutations affecting carotenoid production |
| 01/12/2006 | WO2004031354A3 Human sarcoma-associated antigens |
| 01/12/2006 | WO2004020598A8 Abiz phage resistance gene |
| 01/12/2006 | WO2003089596A3 Novel prostate tumor-specific promoter |
| 01/12/2006 | WO2003087758A3 Peptides for detection of antibody to a. phagocytophila |
| 01/12/2006 | US20060010520 Fertile transgenic corn plants |
| 01/12/2006 | US20060010518 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
| 01/12/2006 | US20060010516 Cell cycle genes and related methods |
| 01/12/2006 | US20060010512 Nitrogen transport metabolism |
| 01/12/2006 | US20060009634 Proteins and nucleic acids encoding same |
| 01/12/2006 | US20060009633 Complementary DNAs encoding proteins with signal peptides |
| 01/12/2006 | US20060009631 Nucleic acids encoding this enzyme; in humans, rodents; isotopes; purity; gene expression; transformation, translation of cells; sulfation of tyrosine; hybridization |
| 01/12/2006 | US20060009625 Performed in a relatively short period of time, involves inexpensive reagents, and requires little sample preparation before and during the purification process |
| 01/12/2006 | US20060009624 Phosphoramidites of substituted cyclic (cyclopentene, cyclohexene, and cyclohepene) bridged cyanine dyes, particularly those containing a N,N-diisopropyl-O- beta -cyanoethyl phosphoramidite group; preparation and use in labeling oligonucleotides, proteins and peptides |
| 01/12/2006 | US20060009623 C-terminal attachment of ligands to proteins for immobilization onto a support |
| 01/12/2006 | US20060009622 inflammatory bowel disease, rheumatoid arthritis, acromegaly, tuberculosis, tumor of the lung, breast, brain, eye, prostate or colon, a tumor of neuroendocrine origin, an angiogenesis disease that causes inappropriate proliferation of blood vessels, retinal macular degeneration or diabetic neuropathy |
| 01/12/2006 | US20060009620 Protein structures and protein fibres |
| 01/12/2006 | US20060009619 Polypeptide sequences related to ricin A chain but lack or have reduced detectable N-glycosidase-rRNA activity; treating or preventing ricin intoxication |
| 01/12/2006 | US20060009618 Expression receptors with 7 transmembrane domains in baculovirus-insect cell system |
| 01/12/2006 | US20060009452 Therapeutic targeting of PARC/CCL18 and its signaling in pulmonary fibrosis |
| 01/12/2006 | US20060009444 Method for decreasing depression by inhibiting the activity of n-type calcium channel |
| 01/12/2006 | US20060009441 Human trace amine associated receptors |
| 01/12/2006 | US20060009383 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 01/12/2006 | US20060009381 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060009379 Methods for controlling proliferation of cells |
| 01/12/2006 | US20060009378 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 01/12/2006 | US20060009377 Long lasting synthetic glucagon like peptide (GLP-1) |
| 01/12/2006 | US20060009376 storable medicaments produced from active ingredient which are virus safe; has a therapeutic protein selected from fibrinogen, Factor VIII, Factor V, Factor XIII, clotting Factors II, VII, IX and X of the prothrombin complex, and an atoxic, virus-safe protease inhibitor |
| 01/12/2006 | US20060009374 Antibacterial peptide |
| 01/12/2006 | US20060008901 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/12/2006 | US20060008900 Pigment epithelium-derived factor: characterization, genomic organization and sequence of the PEDF gene |
| 01/12/2006 | US20060008894 Yeast model for amyloidogenic protein toxicity |
| 01/12/2006 | US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody |
| 01/12/2006 | US20060008881 Mammalian diabetes-mediating proteins |
| 01/12/2006 | US20060008880 Mouse trace amine associated receptors and polypeptides |
| 01/12/2006 | US20060008878 Monomeric red fluorescent proteins |
| 01/12/2006 | US20060008877 Expression systems with sec-system secretion |
| 01/12/2006 | US20060008875 Novel TFIIH subunit |
| 01/12/2006 | US20060008873 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
| 01/12/2006 | US20060008872 substitutes valine for phenylalanine residue in an alpha -helix domain participating in the binding of a human cytokine protein to a corresponding receptor |
| 01/12/2006 | US20060008870 Method for universal enzymatic production of bioactive peptides |
| 01/12/2006 | US20060008858 Osteoblast factor(s) that regulates human prostate cancer migration to and invasion of bone |
| 01/12/2006 | US20060008857 Cap-binding protein |
| 01/12/2006 | US20060008856 Mass tags for quantitative analysis |
| 01/12/2006 | US20060008855 Promiscuous G-protein compositions and their use |
| 01/12/2006 | US20060008853 Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same |
| 01/12/2006 | US20060008846 Methods are described for the screening and identification of antagonist for TGF- beta superfamily members, in particular activin-A antagonist; antagonism of TGF- beta receptors by variants of the TGF- beta superfamily of ligands |
| 01/12/2006 | US20060008845 Polypeptide compositions formed using a coiled-coil template and methods of use |
| 01/12/2006 | US20060008844 Polypeptides comprising monomer domains that bind to c-MET; polynucleotide encoding the polypeptide; cancer; drug screening |
| 01/12/2006 | US20060008820 Cell cycle genes in plants |
| 01/12/2006 | US20060008819 Novel 38594, 57312, 53659, 57250, 63760, 49938, 32146, 57259, 67118, 67067, 62092, FBH58295FL, 57255, and 57255alt molecules and uses therefor |
| 01/12/2006 | US20060008802 Method for the identification of inhibitors of the binding of are-containing mrna and a hur protein |
| 01/12/2006 | US20060008801 Molecules associating to c-terminal domain in receptor cell |
| 01/12/2006 | US20060008800 Unc-13 in the modulation of neurotransmission and secretion events |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008479 Methods and compositions to generate immunity in humans against self tumor antigens by immunization with homologous foreign proteins |
| 01/12/2006 | US20060008477 Phenotype-determining virulence genes of pseudomonas aeruginosa for colonization and persistence in human beings, animals and plants, uses of said gene and associated proteins |
| 01/12/2006 | US20060008475 Shiga toxin B-subunit as a vector for tumor diagnosis and drug delivery to Gb3 expressing tumors |
| 01/12/2006 | US20060008474 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 01/12/2006 | US20060008473 Influenza hemagglutinin and neuraminidase variants |
| 01/12/2006 | US20060008470 Use of vaccinia virus deleted for the E3L gene as a vaccine vector |
| 01/12/2006 | US20060008467 Human immunodeficiency virus vaccine |
| 01/12/2006 | US20060008465 Novel methods for therapeutic vaccination |
| 01/12/2006 | US20060008464 Histone conjugates and uses thereof |
| 01/12/2006 | US20060008463 Tumor antigen peptides derived from cyclophilin B |
| 01/12/2006 | US20060008460 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease |
| 01/12/2006 | US20060008440 Cosmetic or dermatological preparations having a content of anti-freezing proteins and/or anti-freezing glycoproteins |
| 01/12/2006 | DE102004031116A1 Verfahren zum Auffinden schmerzrelevanter Substanzen unter Verwendung schmerzrelevanter Proteine A method for finding relevant substances pain using pain-relevant proteins |
| 01/12/2006 | DE102004030938A1 Neue, Polyaminosäuren bildende oder abbauende Genprodukte von Bacillus licheniformis und darauf aufbauende verbesserte biotechnologische Produktionsverfahren New, Fine polyamino acids or degrading gene of Bacillus licheniformis, upon which improved biotechnological production |
| 01/12/2006 | CA2572707A1 Annexins, derivatives thereof, and annexin-cys variants, as well as therapeutic and diagnostic uses thereof |